Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
nVenue
United States
- Dallas, Texas
- 03/03/2022
- Seed
- $3,500,000
nVenue’s unmatched technology leverages the power of machine learning and artificial intelligence to quickly and accurately generate probabilities for every outcome of a play. nVenue is the future of micro-betting technology. Our products are now live for MLB and NFL games.
Our NextPlay data feed allows sports betting operators to introduce thousands of new micro-markets for baseball (MLB) and football (NFL) while also offering rich, entertaining content for fans to consume.
- Industry Technology, Information and Internet
- Website https://www.nvenue.com/
- LinkedIn https://www.linkedin.com/company/nvenue/about/
Related People
Kelly PrachtFounder
United States -
Houston, Texas
Innovating in sports, mobile and games with smidgens of AI to make amazing and new experiences for sports fans. Day to day you can find me meeting with investors, coding, working bus dev, talking UX/UI, and getting to innovate real time games that are incredibly fun by watching baseball /football/ basketball! Leading a startup is a blast!
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)